Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 6 Oct 2005 |
| Genmab, Bo Kruse Appointed as CFO of Genmab A/S | 30 Sept 2005 |
| InvestorService: Genmab, to Present at FT Global Pharmaceutical and Biotechnology Conference | 30 Sept 2005 |
| InvestorService: Genmab, to Present at UBS Global Life Sciences Conference | 26 Sept 2005 |
| Genmab, Grant of Warrants | 21 Sept 2005 |